The recent surge of DNA sequence information resulting from deciphering the human genetic code has acted as a catalyst for innovative technological developments that have been vital in the identification of genes associated with disease pathologies. This has allowed for the development of novel genetic therapies to treat a wide range of inherited disorders.
The new genomic era heralds earlier diagnoses, greatly improved prevention and treatment of diseases and enhanced avoidance of side effects from drugs.
Now, the latest information and findings that have an impact on the understanding and management of human health and disease will be available online to physicians around the globe with the launch of BioMed Central's premier medical journal Genome Medicine.
Today, Genome Medicine, an online peer-reviewed open access research journal will be launched at a special event at the 58th annual meeting of the American Society of Human Genetics (ASHG), in Philadelphia.
The launch issue is sponsored by Agilent, the electronic and bio-analytical measurement company. In addition to publishing high-quality research, Genome Medicine serves the international research community as a forum for the discussion and critical review of information about all areas of medicine informed by genomic research.
Genome Medicine will focus on the following areas:
- Significant advances in the understanding of the genetics, genomics, and epigenetics of disease
- Computational and systems approaches, including proteomics, metabolomics and transcriptomics, to the understanding and management of disease
- Genomic epidemiology and public health genomics
- The application of genomic and post-genomic technologies to clinical practice, with special emphasis on diagnostics and therapeutics
- Personalized medicine
- Ethical, social and legal issues relating to genomic medicine and personalized medicine
Speaking of his support for the new journal, Charles Auffray of the Functional Genomics and Systems Biology for Health, Centre National de la Recherche Scientifique (CNRS), France and Section Editor said, "High-throughput experimental and computational technologies are revolutionizing our understanding of life by enabling global systems approaches beyond classical analytical molecular and cellular biology. Genome Medicine is a timely initiative to foster this transition from the highly fragmented scientific and medical landscape to the integrative systems biology and medicine which are needed to translate fundamental discoveries into useful healthcare services for the benefit of individual patients worldwide."
Notes to Editors
Launch Event
Wednesday 12 November 18.30 – 20.30
Loews Philadelphia Hotel
Solstice Private Dining Room
1200 Market Street
Philadelphia, Pennsylvania 19107
BioMed Central will be exhibiting at booth 812 at the American Society of Human Genetics (ASHG)
Genome Medicine (http://www.genomemedicine.com/) is an online peer-reviewed journal which publishes open access research articles of outstanding quality in all areas of medicine studied from a genomic or post-genomic perspective. The journal will have a special focus on the latest technologies and findings that have an impact on the understanding and management of human health and disease.
BioMed Central (http://www.biomedcentral.com/) is an STM (Science, Technology and Medicine) publisher which has pioneered the open access publishing model. All peer-reviewed research articles published by BioMed Central are made immediately and freely accessible online, and are licensed to allow redistribution and reuse. BioMed Central is part of Springer Science+Business Media, a leading global publisher in the STM sector.
Journal
Genome Medicine